ID: ALA5269836

Max Phase: Preclinical

Molecular Formula: C16H16O4

Molecular Weight: 272.30

Associated Items:

Representations

Canonical SMILES:  CC1c2cc(O)c(O)cc2-c2c(ccc(O)c2O)C1C

Standard InChI:  InChI=1S/C16H16O4/c1-7-8(2)10-5-13(18)14(19)6-11(10)15-9(7)3-4-12(17)16(15)20/h3-8,17-20H,1-2H3

Standard InChI Key:  XHQUBMHYDAUWSE-UHFFFAOYSA-N

Associated Targets(Human)

Alpha-synuclein 10960 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 272.30Molecular Weight (Monoisotopic): 272.1049AlogP: 3.40#Rotatable Bonds: 0
Polar Surface Area: 80.92Molecular Species: NEUTRALHBA: 4HBD: 4
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.95CX Basic pKa: CX LogP: 3.54CX LogD: 3.53
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.55Np Likeness Score: 1.45

References

1. Bernardes G, Munir O, Krol ES..  (2023)  The effect of diphenylethane side-chain substituents on dibenzocyclohexadiene formation and their inhibition of α-synuclein aggregation in vitro.,  78  [PMID:36587551] [10.1016/j.bmc.2022.117147]

Source